Section
The Week
Weekly roundup of what mattered and why
The WeekFiercePharma ↗
With a pediatric approval in hand for Afrezza, MannKind may finally have the boost it needs to make an impact …
The WeekFierceBiotech ↗
Nine years after wowing the audience at the American Society of Clinical Oncology annual meeting with a CAR-T …
The WeekBriefing
Allogene’s founding CEO steps down, Agios halts development of tebapivat, AbbVie gains approval for Decnupaz, …
The WeekSTAT News ↗
Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own stra…
The WeekAJMC ↗
A Framework for Palliative Care Integration in Cancer Care: Biren Saraiya, MD…
The WeekBioPharma Dive ↗
Study results accrued so far are giving Merck greater conviction that the therapy, licensed from a China-based…
Page 1
Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.